Updated: May 19, 2026

Susan Molineaux

GERNGERON CORPSEC CIK: 0001553389
Estimated Net Worth
-$215 Thousand0.0%vs Last Year
Last Updated: May 19, 2026 02:22 AM EST

Transaction Summary

Total Transactions75
Buy-Sell Ratio2.00
Buy Transactions2
Sell Transactions1

Transaction Volume

Total Volume$236.58K
Net Volume$333.18K
Buy Volume$284.88K
Sell Volume-$48.30K

Trade Analysis

AVG Trade Size$7.74K
Largest Trade$200.21K
Most Active MonthMay
Most Active Year2023

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Susan Molineaux does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Theravance Biopharma, Inc., GERON CORP, Cyteir Therapeutics, Inc., Calithera Biosciences, Inc., and Repare Therapeutics Inc..



2015 was Susan Molineaux's most active year for acquiring shares with 12 total transactions. Susan Molineaux's most active month to acquire stocks was the month of April. 2015 was Susan Molineaux's most active year for disposing of shares, totalling 8 transactions. Susan Molineaux's most active month to dispose stocks was the month of November. 2015 saw Susan Molineaux paying a total of $151,415.76 for 384,458 shares, this is the most they've acquired in one year. In 2023 Susan Molineaux cashed out on 70,000 shares for a total of $86,800.00, their largest year based on trade value.

Holdings & Transactions

GERNgeron corp
Updated: May 22, 2025VIEW QUOTE
Form TypeSEC Filing
180.00K180.00KMay 21View
180.00K180.00KMay 09View
0.056.22K130.53KDec 29View
0.056.19K124.31KSep 29View
0.044.09K118.12KJun 30View
125.00K125.00KMay 31View
-1.0035.00K$1.79-$48.30KMay 01View
0.066.05K114.03KMar 31View
125.00K125.00KMay 10View
83.00K83.00KMay 11View
83.00K83.00KJun 05View
70.00K70.00KJun 06View
0.1413.13K107.98KDec 31View
0.097.46K94.86KSep 28View
0.053.83K87.40KJun 29View
70.00K70.00KMay 15View
0.043.09K83.57KMar 29View
0.107.29K80.48KDec 29View
0.096.02K73.19KSep 29View
0.084.74K67.17KJun 30View
50.00K50.00KMay 09View
0.105.78K62.43KMar 31View
0.136.34K56.65KDec 30View
0.135.81K50.31KSep 30View
0.124.90K44.50KJun 30View
50.00K50.00KMay 17View
0.134.50K39.60KMar 31View
0.082.71K35.11KDec 31View
0.174.75K32.40KSep 30View
0.123.07K27.64KJun 30View
35.00K35.00KMay 18View
0.173.48K24.58KMar 31View
0.244.04K21.09KDec 31View
0.324.09K17.06KJun 30View
35.00K35.00KMay 20View
0.946.28K12.97KMar 31View
0.712.77K6.69KDec 31View
3.92K3.92KSep 30View
35.00K35.00KMay 22View
70.00K70.00KSep 26View
View
RPTXrepare therapeutics inc.
Updated: Jun 20, 2024VIEW QUOTE
Form TypeSEC Filing
27.20K27.20KJun 17View
76.20K76.20KJun 08View
View
CYTcyteir therapeutics, inc.
Updated: Feb 07, 2023VIEW QUOTE
Form TypeSEC Filing
14.15K14.15KFeb 03View
14.15K14.15KFeb 22View
View
CALAcalithera biosciences, inc.
PRESIDENT & CEO Director
Updated: Jan 25, 2023VIEW QUOTE
Form TypeSEC Filing
-0.02526.00$0.45-$234.6537.87KJan 23View
597.48K597.48KJan 25View
0.22100.00K$0.85$84.67K757.19KNov 10View
46.00460.00K979.19KJan 20View
400.00K400.00KJan 18View
0.1351.60K$3.88$200.21K462.19KJun 25View
-0.0312.99K395.59KFeb 07View
390.00K390.00KJan 10View
-0.026.48K413.57KNov 14View
-0.116.80K$2.64$71.26K424.78KMar 02View
200.00K200.00KJan 11View
-0.149.20K$1.65$21.26K416.30KDec 05View
-0.1010.17K$2.16$47.31K414.78KDec 19View
165.00K165.00KNov 29View
-0.0912.34K$1.81$53.22K401.30KJul 20View
185.00K185.00KJan 19View
-0.0410.17K$1.49$41.53K406.03KDec 21View
-0.0924.38K$1.44$109.89K401.03KJul 13View
227.35K227.35KFeb 11View
117.96KView
TBPHtheravance biopharma, inc.
Updated: Apr 29, 2021VIEW QUOTE
Form TypeSEC Filing
15.83K57.03KApr 27View
12.63K47.21KApr 28View
14.38K40.57KApr 30View
2.3614.19K32.19KMay 01View
1.006.00K18.00KMay 17View
6.00K12.00KMay 03View
18.00K18.00KApr 22View
View